. "Editorial Note: The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease." PLoS ONE, 2025. doi:10.1371/journal.pone.0334975